The history of 20th century malaria control in Peru

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Griffing, Sean M ^a,b   Gamboa, Dionicia ^c,d   Udhayakumar, Venkatachalam ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Disease; Drug resistance; Falciparum; Habitat change; Latin America; Malaria; Malaria control; Malaria eradication; Peru; Pesticide resistance; Plasmodium; Public health; Vivax

Indexed keywords

ARTEMISININ; ARTESUNATE; CHLOROQUINE; CHLORPHENOTANE; CLINDAMYCIN; INSECTICIDE; MEFLOQUINE; MEPACRINE; PLASMOQUINE; PRIMAQUINE; PYRETHROID; QUININE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT;

DOMESTIC PARTNERSHIP; EPIDEMIC; ERADICATION THERAPY; HEALTH CARE POLICY; HUMAN; INCIDENCE; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MORBIDITY; NONHUMAN; PARASITE VECTOR; PERU; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLITICAL SYSTEM; POPULATION DYNAMICS; PUBLIC HEALTH; REVIEW; DRUG THERAPY; HISTORY; INFECTION CONTROL; METHODOLOGY;

ANTIMALARIALS; COMMUNICABLE DISEASE CONTROL; DRUG THERAPY; HEALTH POLICY; HISTORY, 20TH CENTURY; HUMANS; MALARIA; PERU; QUININE;

EID: 84883151957     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-303     Document Type: Review

References (46)

1. Treatment of malaria. Poser CM, Bruyn GW, An illustrated history of malaria New York: The Parthenon Publishing Group Inc 1999 76 90
2. Cueto M, Identidad regional y malaria en el Peru del siglo viente Lima, Peru: Instituto de Estudios Peruanos, Talleres de Tarea Asociacion Grafica Educativa El regreso de las epidemias: salud y sociedad en en el Peru del siglo XX. 1997 127 172
3. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Marquino W, Ylquimiche L, Hermenegildo Y, Palacios A, Falconi E, Cabezas C, Arrospide N, Gutierrez S, Ruebush T, Am J Trop Med Hyg 2005 72 568 572 15891131 (Pubitemid 41278825)
4. WHO, Situación de los programas de malaria en las Américas, XXXIX informe Washington, DC: Pan American Health Organization Organizacion panamerica de la salud. 1991
5. Modifying national malaria treatment policies in Peru. Ruebush T, Neyra D, Cabezas C, J Public Health Policy 2004 25 328 345 10.1057/palgrave.jphp. 3190032 15683069 (Pubitemid 40017478)
6. PAHO, Informe de la situación del paludismo en las Américas, 2008 Washington, DC: Pan American Health Organization 2010
7. Organismo Andino de Salud, El impacto de las reformas en salud Colombia, Ecuador, Peru y Venezuela, en la situacion de malaria Fundación para la Investigación y Desarrollo de la Salud y la Seguridad Social 2007
8. Franco Agudelo S, El paludismo en América Latina Guadalajara: Editorial Universidad de Guadalajara 1990
9. Fosdick R, The Rockefeller foundation annual report New York: The Rockefeller Foundation 1941
10. Pan American Committee on Sanitary Engineering, Report of the Pan American committee on sanitary engineering Washington, DC: PAHO Bulletin of the Pan American sanitary office, vol. 23. 1944
11. Fosdick R, The Rockefeller foundation annual report New York: The Rockefeller Foundation 1943
12. Harinasuta T, Migasen S, Bunnag D, Chloroquine resistance in Plasmodium falciparum in Thailand Singapore: University of Singapore UNESCO first regional symposium on scientific knowledge of tropical parasites university of Singapore, Singapore. 1962 148 153
13. Fosdick R, The Rockefeller foundation annual report New York: The Rockefeller Foundation 1944
14. The cycles of eradication: the Rockefeller foundation and Latin American public health, 1918-1940. Cueto M, International health organisations and movements New York: Cambridge University Press, Weindling P, 1995 222 243
15. Fosdick R, The Rockefeller foundation annual report New York: The Rockefeller Foundation 1948
16. Malaria Plasmodium falciparum en adultos hospitalizados de iquitos: aspectors clinocs y epidemiologicos. Quino H, Durand S, Maguiña C, Acta Médica Peruana 2001 18 52 57 23999293
17. Malaria reemergence in the Peruvian Amazon region. Aramburu GJ, Ramal AC, Witzig R, Emerg Infect Dis 1999 5 209 215 10221872 (Pubitemid 29200618)
18. Natural plasmodium infections in Anopheles darlingi and Anopheles benarrochi (diptera: culicidae) from eastern Peru. Flores-Mendoza C, Fernández R, Escobedo-Vargas K, Vela-Perez Q, Schoeler G, J Med Entomol 2004 41 489 494 10.1603/0022-2585-41.3.489 15185955 (Pubitemid 38693200)
19. The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of falciparum malaria in the Peruvian Amazon. Vittor A, Gilman R, Tielsch J, Glass G, Shields T, Lozano W, Pinedo-Cancino V, Patz J, Am J Trop Med Hyg 2006 74 3 11 16407338 (Pubitemid 46768622)
20. Alhalel B, Infecciones emergentes y reemergentes en el Peru Lima: Academia Nacional de Medicina Anales de la academia de medicina. 2002
21. Evaluación in vivo de la respuesta de Plasmodium falciparum a la cloroquina en foco carretera yurimaguas-tarapoto (región Loreto). Chauca H, Quintana J, Revista Peruana de Epidemiología 1993 6 34 39
22. PAHO, Epidemiology and control of falciparum malaria in the Americas Washington, DC: Pan American Health Organization vol. Scientific publication No. 471. 1984
23. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, Haley R, Tsukayama P, Lucas C, Escalante AA, Venkatachalam U, Antimicrob Agents Chemother 2009 53 2042 2051 10.1128/AAC.01677-08 19258269
24. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Marquino W, MacArthur J, Barat L, Oblitas F, Arrunategui M, Garavito G, Chafloque M, Pardave B, Gutierrez S, Arrospide N, Am J Trop Med Hyg 2003 68 120 12557836
25. Unusual pattern of Plasmodium falciparum drug resistance in the northwestern Peruvian Amazon region. Durand S, Marquino W, Cabezas C, Utz G, Fiestas V, Cairo J, Puray M, Lucas C, Salas C, Gutierrez S, Am J Trop Med Hyg 2007 76 614 17426158
26. Situacion de los programas de malaria en las Americas, XLIV informe Washington, DC: Pan American Health Organization Organizacion panamericana de la salud, XXXIX reunion and organizacion mundial de la salud, XLVIIII reunion. 1996
27. Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Vittor A, Pan W, Gilman R, Tielsch J, Glass G, Shields T, Sanchez-Lozano W, Pinedo V, Salas-Cobos E, Flores S, Patz J, Am J Trop Med Hyg 2009 81 5 42 19556558
28. Especies de la fauna anofelina, su distribución y algunas consideraciones sobre su abundancia e infectividad en el Perú Calderón G, Fernández R, Valle J, Revista Peruana de Epidemología 1995 8 5 23 23085789
29. Genesis of chloroquine-resistant Plasmodium falciparum in the America region. Clyde DF, La Medicina Tropicale Nella Cooperazione Allo Sviluppo 1987 3 41 44
30. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Williams H, Vincent-Mark A, Herrera Y, Chang OJ, Malar J 2009 8 85 10.1186/1475-2875-8-85 19400953
31. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Magill A, Zegarra J, Garcia C, Marquiño W, Ruebush T II, Rev Soc Bras Med Trop 2004 37 273 278 15330069
32. Surveillance for adverse drug reactions to combination antimalarial therapy with sulfadoxine-pyrimethamine plus artesunate in Peru. Cairo J, Durand S, Marquino W, Cabezas C, Lachira A, Quintana F, Vegas W, Ruebush T, Utz G, Bacon D, Am J Trop Med Hyg 2008 79 42 18606762
33. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Zhou Z, Griffing SM, de Oliveira AM, McCollum AM, Quezada WM, Arrospide N, Escalante AA, Udhayakumar V, Antimicrob Agents Chemother 2008 52 739 741 10.1128/AAC.00975-07 18025120 (Pubitemid 351170855)
34. Costo efectividad del cambio de los esquemas de tratamiento para malaria en el Perú (1999-2003). Sánchez C, Durand S, Revista Peruana de Medicina Experimental y Salud Pública 2004 21 197 209
35. Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study. Van den Eede P, Soto-Calle VE, Delgado C, Gamboa D, Grande T, Rodriguez H, Llanos-Cuentas A, Anné J, D'Alessandro U, Erhart A, PLoS ONE 2011 6 16257 10.1371/journal.pone.0016257 21297986
36. Adherence to 7-Day primaquine treatment for the radical cure of P. Vivax in the Peruvian Amazon. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, Montalvo TG, Rodriguez H, Cuentas AL, D'Alessandro U, Gamboa D, Am J Trop Med Hyg 2010 82 1017 1023 10.4269/ajtmh.2010.09-0521 20519594
37. Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon. Parekh FK, Hernandez JN, Krogstad DJ, Casapia WM, Branch OH, Am J Trop Med Hyg 2007 77 451 457 17827359 (Pubitemid 351844318)
38. Chloroquine-resistant Plasmodium vivax malaria in Peru. Ruebush TK, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquino W, Huilca M, Arevalo E, Garcia C, Am J Trop Med Hyg 2003 69 548 552 14695094 (Pubitemid 38248258)
39. Molecular assays for surveillance of antifolate-resistant malaria. Kublin JG, Witzig RS, Shankar AH, Zurita JQ, Gilman RH, Guarda JA, Cortese JF, Plowe CV, Lancet 1998 351 1629 1630 10.1016/S0140-6736(98)24022-0 9620719 (Pubitemid 28252181)
40. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. Cortese JF, Caraballo A, Contreras CE, Plowe CV, J Infect Dis 2002 186 999 1006 10.1086/342946 12232841
41. Plasmodium falciparum genetic diversity maintained and amplified over 5 years of a low transmission endemic in the Peruvian Amazon. Branch OH, Sutton PL, Barnes C, Castro JC, Hussin J, Awadalla P, Hijar G, Mol Biol Evol 2011 28 1973 1986 10.1093/molbev/msq311 21109587
42. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Branch OL, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E, Malar J 2005 4 27 10.1186/1475-2875-4- 27 15975146 (Pubitemid 41214251)
43. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Chenet SM, Branch OH, Escalante AA, Lucas CM, Bacon DJ, Malar J 2008 7 93 10.1186/1475-2875-7-93 18505558 (Pubitemid 351862287)
44. Plasmodium falciparum and Plasmodium vivax infections in the Peruvian Amazon: propagation of complex, multiple allele-type infections without super-infection. Sutton PL, Neyra V, Hernandez JN, Branch OH, Am J Trop Med Hyg 2009 81 950 960 10.4269/ajtmh.2009.09-0132 19996422
45. South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. Griffing SM, Mixson-Hayden T, Sridaran S, Alam MT, McCollum AM, Cabezas C, Quezada WM, Barnwell JW, De Oliveira AM, Lucas C, PLoS ONE 2012 6 23486
46. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. Gamboa D, Ho M-F, Bendezu J, Torres K, Chiodini PL, Barnwell JW, Incardona S, Perkins M, Bell D, McCarthy J, PLoS ONE 2010 5 8091 10.1371/journal.pone.0008091 20111602